Vaccines, blood, antisera, toxins and cultures in   France

Exports In 2023, France exported $10.6B in Vaccines, blood, antisera, toxins and cultures, making it the 9th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 11th most exported product in France. The main destination of Vaccines, blood, antisera, toxins and cultures exports from France are: Germany ($2.07B), Belgium ($1.42B), United States ($796M), China ($620M), and Italy ($523M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of France between 2022 and 2023 were United States ($262M), Ireland ($129M), and United Kingdom ($96M).

Imports In 2023, France imported $15.9B in Vaccines, blood, antisera, toxins and cultures, becoming the 6th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 7th most imported product in France. France imports Vaccines, blood, antisera, toxins and cultures primarily from: Netherlands ($2.84B), South Korea ($2.31B), Belgium ($2.31B), Ireland ($2.03B), and Germany ($1.96B).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for France between 2022 and 2023 were South Korea ($2.15B), Ireland ($893M), and Netherlands ($474M).